Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma
Clinical trial NCT01585974 · COMPLETED
Trial details
- NCT number
- NCT01585974
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-06-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.